Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Urologia Internationalis|August 3, 2017
Prospective, Controlled Study of Invasiveness and Post-Aggression Metabolism in Patients Undergoing Robotic-Assisted Radical ProstatectomyAndreas Martinschek, Lisa Stumm, Manuel Ritter, et al.
Diagnostic Pathology|October 10, 2012
Leiomyoma of the tunica albuginea, a case report of a rare tumour of the testis and review of the literatureFelix Bremmer, Felix J Kessel, Carl L Behnes, et al.
The Prostate|September 21, 2002
Neuroendocrine differentiation of human prostatic primary epithelial cells in vitroHolger Rumpold, Elmar Heinrich, Gerold Untergasser, et al.
The Prostate|April 12, 2011
Neuroendocrine tumor cells in prostate cancer: evaluation of the neurosecretory products serotonin, bombesin, and gastrin - impact on angiogenesis and clinical follow-upElmar Heinrich, Lutz Trojan, Dorothee Friedrich, et al.
Journal of Endourology|December 5, 2009
120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo modelElmar Heinrich, Gunnar Wendt-Nordahl, Patrick Honeck, et al.
The Prostate|January 19, 2016
Influence of abiraterone acetate on circulating neuromediators in chemotherapy-naïve castration-resistant prostate cancerJost von Hardenberg, Maike Schwartz, Thorsten Werner, et al.
Anticancer Research|September 6, 2017
Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During DocetaxelJost VON Hardenberg, Maike Schwartz, Thorsten Werner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2007
Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxelStefan Buchholz, Andrew V Schally, Jörg B Engel, et al.
Urologia Internationalis|July 13, 2017
Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature ReviewJost von Hardenberg, Maike Schwartz, Thorsten Werner, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2006
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinationsStefan Buchholz, Gunhild Keller, Andrew V Schally, et al.
Pageof 3